Startseite
lx arp1
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway, Journal of Translational Medicine

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway, Journal of Translational Medicine

5 (723) · € 27.99 · Auf Lager

Biomolecules, Free Full-Text

Cancers, Free Full-Text

Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma - ScienceDirect

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway, Journal of Translational Medicine

TRAF2 KO inhibits apoptosis induced by IMiDs through enhancing

MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis - Trang T. Pham, Steven P. Angus, Gary L. Johnson, 2013

A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation

Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066